Tirzepatide - Eli Lilly and Company
At a glance
- Drug Originator Eli Lilly and Company
- Drug Class Antihyperglycaemics; Glucagon-like peptides; Heart failure therapies; Hepatoprotectants; Obesity therapies
- Mechanism of Action Gastric inhibitory polypeptide receptor agonists; Glucagon like peptide 1 receptor agonists
- USA Patent Applicants ELI LILLY AND CO
- USA Patents 4
- NDAs 2
- International Patents 150
Table of Contents

Disclaimer